Results
Differentially Expressed miRNAs List
miRNA ID | Source ID | Cancer Type | Cancer Subtype | Cell Line | Design | logFC | Expression Status | Experiment ID |
---|---|---|---|---|---|---|---|---|
hsa-miR-33b | GSE18392 | colon cancer | colon cancer | N/A | cancer vs normal | 0.71 | UP | EXP00090 |
hsa-miR-33b | GSE21036 | prostate cancer | prostate cancer | N/A | cancer vs normal | 0.53 | UP | EXP00101 |
hsa-miR-33b | GSE21036 | prostate cancer | prostate cancer | N/A | metastasis | 1.22 | UP | EXP00102 |
hsa-miR-33b | GSE6857 | hepatocellular carcinoma | hepatocellular carcinoma | N/A | cancer vs normal | -0.31 | DOWN | EXP00081 |
hsa-miR-33b | GSE15008 | lung cancer | lung cancer | N/A | cancer vs normal | 0.32 | UP | EXP00070 |
hsa-miR-33b | GSE18392 | colon cancer | colon cancer | N/A | cancer vs normal | 0.51 | UP | EXP00091 |
hsa-miR-33b | GSE18392 | colon cancer | colon cancer | N/A | cancer vs normal | 0.66 | UP | EXP00092 |
hsa-miR-33b | GSE18392 | colon cancer | colon cancer | N/A | cancer vs normal | 0.83 | UP | EXP00093 |
hsa-miR-33b* | GSE21036 | prostate cancer | prostate cancer | N/A | metastasis | 0.69 | UP | EXP00102 |
hsa-miR-33b | GSE21036 | prostate cancer | prostate cancer | N/A | high grade vs low grade | 1.37 | UP | EXP00104 |
hsa-miR-33b | GSE21036 | prostate cancer | prostate cancer | N/A | high grade vs low grade | 1.17 | UP | EXP00106 |
hsa-miR-33b | GSE22216 | breast cancer | breast cancer | N/A | high grade vs low grade | 0.77 | UP | EXP00125 |
hsa-miR-33b | GSE22216 | breast cancer | breast cancer | N/A | high grade vs low grade | 0.97 | UP | EXP00126 |
hsa-miR-33b* | GSE25820 | pancreatic cancer | pancreatic cancer | N/A | cancer vs normal | -1.07 | DOWN | EXP00135 |
hsa-miR-33b* | GSE25820 | pancreatic cancer | pancreatic cancer | N/A | cancer vs normal | -1.12 | DOWN | EXP00136 |